|
Numerous clients have already trusted the OPTIMARC CRAs in the various therapeutic fields described in the following table.
|
PATHOLOGY
|
PHASE
|
NUMBER OF SITES
|
NUMBER OF PATIENTS
|
|
Lung cancer
|
II
|
14
|
86
|
|
Lung cancer
|
II
|
15
|
60
|
|
Hépatitis C
|
Pharmaco-epidemiological study
|
200
|
-
|
|
Myocardial infarction
|
Epidemiological Inquiry
|
176
|
968
|
|
Glaucoma
|
Observationnal Inquiry
|
71
|
142
|
|
Infectiology
|
IIIb
|
39
|
-
|
|
Lung cancer
|
II
|
47
|
132
|
|
Lung cancer
|
II
|
25
|
100
|
|
Epilepsy
|
III
|
24
|
-
|
|
Menopause
|
III
|
39
|
135
|
|
Depressive syndroma
|
IV
|
42
|
45
|
|
Influenza
|
Pharmaco-epidemiological study
|
200
|
-
|
|
Pancreas cancer
|
III
|
17
|
77
|
|
Hypercholesterolaemia
|
III
|
36
|
-
|
|
High Blood Pressure
|
IV
|
559
|
-
|
|
Presbytia
|
IV
|
6
|
100
|
|
Vertebral fracture
|
Medico-economic study
|
82
|
-
|
|
antibiotherapy and vaccination for dogs and cats
|
III and IV
|
6
|
10
|
|
VIH
|
IIIb
|
6
|
49
|
|
Contraception
|
III
|
65
|
223
|
|
Intertrigo
|
IV
|
25
|
-
|
|
Children's diarrhea
|
III
|
24
|
420
|
|
Pollakuiria
|
IIb
|
3
|
-
|
|
Anemia
|
Pharmaco-epidemiological study
|
250
|
-
|
|
Lung cancer
|
II
|
9
|
60
|
|
Influenza
|
Pharmaco-epidemiological study
|
100
|
-
|
|
Hypogonadism
|
III
|
|
|
To this collective experience, each individual’s experience should be added: therapeutic, medical devices, cellular therapy, etc. (nutraceutical, epidemiology, observational, Temporary Utilisation to Use, veterinary projects).
|
And your studies stand out
